Chat with us
Research Assistance
Online
  • Please enter your first name.

North America Immunosuppressant Drugs Market, 2020-2027

The immunosuppressant drugs market in North America is expected to reach a projected revenue of US$ 63,618.9 million by 2027. A compound annual growth rate of 5.8% is expected of North America immunosuppressant drugs market from 2021 to 2027.

  • Pharmaceuticals
    • Metabolic Disorders Treatment
      • Immunosuppressant Drugs Market
Revenue, 2020 (US$M)
$42,849.8
Forecast, 2027 (US$M)
$63,618.9
CAGR, 2021 - 2027
5.8%
Report Coverage
North America

North America Immunosuppressant Drugs Market, 2016-2027 (US$M)

North America Immunosuppressant Drugs Market, 2016-2027 (US$M)

This page contains premium content. Request sample data or start your free trial to explore Horizon.

  • ✔ Access to global market statistics
  • ✔ Access to company profiles
  • ✔ Free use-cases & research insights

No credit card required*

Prism AI by Grand View ResearchFree to try

Ask a question about the immunosuppressant drugs market

Every figure cited from GVR research

North America immunosuppressant drugs market highlights

  • The North America immunosuppressant drugs market generated a revenue of USD 42,849.8 million in 2020.
  • The market is expected to grow at a CAGR of 5.8% from 2021 to 2027.
  • In terms of segment, monoclonal antibodies was the largest revenue generating drug class in 2020.
  • Monoclonal Antibodies is the most lucrative drug class segment registering the fastest growth during the forecast period.
  • Country-wise, Canada is expected to register the highest CAGR from 2021 to 2027.


North America data book summary

Market revenue in 2020USD 42,849.8 million
Market revenue in 2027USD 63,618.9 million
Growth rate5.8% (CAGR from 2020 to 2027)
Largest segmentMonoclonal antibodies
Fastest growing segmentMonoclonal Antibodies
Historical data covered2016 - 2019
Base year for estimation2020
Forecast period covered2021 - 2027
Quantitative unitsRevenue in USD million
Market segmentationCalcineurin Inhibitors, MTOR Inhibitors, Antiproliferative Agents, Monoclonal Antibodies


Other key industry trends

  • In terms of revenue, North America region accounted for 44.7% of the global immunosuppressant drugs market in 2020.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2027.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 33,976.8 million by 2027.

In March 2020, CDC issued guidelines for dental settings in response to the rising number of cases of COVID-19. As per the guidelines, dental settings were recommended to focus only on emergency & urgent visits and postpone all elective visits.

Guidelines by the various regulatory authorities are anticipated to facilitate safe delivery of dental care during the pandemic. According to the North American Dental Group survey, nearly 71% of the participants were unwilling to visit their dentist for nonemergency care due to the COVID 19 concerns.

Thus, fear psychosis coupled with financial issues related to equipment maintenance & facility rent during the lockdown is anticipated to lead to closure of several small dental offices. In addition, inadequate Personal Protective Equipment (PPE) in the region may also hinder growth.

No credit card required*

Customize the Report

20% free customization

Include
Countries, segments, points
Tailor
To your product definition
Extend
Deeper competitor detail
Or
A fully bespoke study

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Immunosuppressant Drugs Market Companies

NameProfile# EmployeesHQWebsite

North America Immunosuppressant Drugs Market

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Immunosuppressant Drugs Market will help companies and investors design strategic landscapes.


Monoclonal Antibodies was the largest segment with a revenue share of 76.01% in 2020.

Horizon Databook has segmented the North America immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.




In March 2020, CDC issued guidelines for dental settings in response to the rising number of cases of COVID-19. As per the guidelines, dental settings were recommended to focus only on emergency & urgent visits and postpone all elective visits.

Guidelines by the various regulatory authorities are anticipated to facilitate safe delivery of dental care during the pandemic. According to the North American Dental Group survey, nearly 71% of the participants were unwilling to visit their dentist for nonemergency care due to the COVID 19 concerns.

Thus, fear psychosis coupled with financial issues related to equipment maintenance & facility rent during the lockdown is anticipated to lead to closure of several small dental offices. In addition, inadequate Personal Protective Equipment (PPE) in the region may also hinder growth.

  • North America Immunosuppressant Drugs Market Drug Class Outlook (Revenue, USD Million , 2016-2027)
    • Calcineurin Inhibitors
    • mTOR Inhibitors
    • Antiproliferative Agents
    • Monoclonal Antibodies
    • Others
  • North America Immunosuppressant Drugs Market Application Outlook (Revenue, USD Million , 2016-2027)
    • Autoimmune Diseases
    • Organ Transplants
    • Other Applications
  • North America Immunosuppressant Drugs Market Route of Administration Outlook (Revenue, USD Million , 2016-2027)
    • Oral
    • Injectables
  • North America Immunosuppressant Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2016-2027)
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy

Reasons to subscribe to Immunosuppressant Drugs Market databook

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Immunosuppressant Drugs Market databook

  • Our clientele includes a mix of Immunosuppressant Drugs Market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America Immunosuppressant Drugs Market, including forecasts for subscribers. This continent databook contains high-level insights into North America Immunosuppressant Drugs Market from 2016 to 2027, including revenue numbers, major trends, and company profiles.

North America Immunosuppressant Drugs Market, 2016-2027 (US$M)

No Access Stack Chart

North America immunosuppressant drugs market statistics, by drug class, 2016-2027 (US$M)

No Access Pie Chart

North America immunosuppressant drugs market statistics, by country, 2016-2027 (USD Million)

No Access

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more